M K Ritke

733 total citations
9 papers, 632 citations indexed

About

M K Ritke is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, M K Ritke has authored 9 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in M K Ritke's work include Cancer therapeutics and mechanisms (5 papers), Lung Cancer Research Studies (3 papers) and Estrogen and related hormone effects (2 papers). M K Ritke is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Lung Cancer Research Studies (3 papers) and Estrogen and related hormone effects (2 papers). M K Ritke collaborates with scholars based in United States and Australia. M K Ritke's co-authors include Jack C. Yalowich, Joyce K. Randolph, Frank A. Fornari, David A. Gewirtz, William P. Allan, Dai Roberts, Jacques Raymond, James M. Rusnak, J S Lazo and Caroline Dive and has published in prestigious journals such as British Journal of Cancer, Journal of Pharmacology and Experimental Therapeutics and Molecular Pharmacology.

In The Last Decade

M K Ritke

9 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M K Ritke United States	9	410	221	90	78	64	9	632
Joyce K. Randolph United States	13	415 1.0×	319 1.4×	95 1.1×	66 0.8×	70 1.1×	23	781
S Kirschenbaum United States	7	576 1.4×	342 1.5×	51 0.6×	104 1.3×	40 0.6×	9	728
Xiaohang Qiao Netherlands	11	481 1.2×	277 1.3×	78 0.9×	75 1.0×	75 1.2×	14	885
Sabina Y. van der Zanden Netherlands	9	295 0.7×	169 0.8×	62 0.7×	57 0.7×	74 1.2×	18	612
Elisabetta Corna Italy	16	454 1.1×	339 1.5×	25 0.3×	47 0.6×	38 0.6×	35	726
Salim Khiati France	18	557 1.4×	145 0.7×	97 1.1×	100 1.3×	43 0.7×	26	791
A. M. Burger United States	15	799 1.9×	368 1.7×	95 1.1×	58 0.7×	81 1.3×	30	1.2k
Federica Bucci Italy	14	428 1.0×	168 0.8×	59 0.7×	121 1.6×	26 0.4×	18	622
H. H. Fiebig Germany	8	229 0.6×	177 0.8×	46 0.5×	121 1.6×	36 0.6×	19	598
Anmada Nayak India	21	542 1.3×	244 1.1×	74 0.8×	179 2.3×	84 1.3×	25	889

Countries citing papers authored by M K Ritke

Since Specialization

Citations

This map shows the geographic impact of M K Ritke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M K Ritke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M K Ritke more than expected).

Fields of papers citing papers by M K Ritke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M K Ritke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M K Ritke. The network helps show where M K Ritke may publish in the future.

Co-authorship network of co-authors of M K Ritke

This figure shows the co-authorship network connecting the top 25 collaborators of M K Ritke. A scholar is included among the top collaborators of M K Ritke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M K Ritke. M K Ritke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Ritke, M K, Nicole R. Murray, William P. Allan, Alan P. Fields, & Jack C. Yalowich. (1995). Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.. Molecular Pharmacology. 48(5). 798–805. 28 indexed citations

Hartsell, Theresa L., et al.. (1995). Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin.. Journal of Pharmacology and Experimental Therapeutics. 275(1). 479–485. 16 indexed citations

Ritke, M K, et al.. (1994). Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells. British Journal of Cancer. 69(4). 687–697. 63 indexed citations

Ritke, M K, James M. Rusnak, J S Lazo, et al.. (1994). Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.. Molecular Pharmacology. 46(4). 605–611. 54 indexed citations

Ritke, M K, Jack C. Yalowich, Marilyn L. Slovak, et al.. (1994). P-glycoprotein mediates profound resistance to bisantrene.. PubMed. 6(7). 291–301. 25 indexed citations

Fornari, Frank A., Joyce K. Randolph, Jack C. Yalowich, M K Ritke, & David A. Gewirtz. (1994). Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.. Molecular Pharmacology. 45(4). 649–656. 367 indexed citations

Ritke, M K, William P. Allan, Cheryl L. Fattman, Nuray Gündüz, & Jack C. Yalowich. (1994). Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.. Molecular Pharmacology. 46(1). 58–66. 35 indexed citations

Gewirtz, David A., Michael S. Orr, Frank A. Fornari, et al.. (1993). Dissociation between bulk damage to DNA and the antiproliferative activity of teniposide (VM-26) in the MCF-7 breast tumor cell line: evidence for induction of gene-specific damage and alterations in gene expression.. PubMed. 53(15). 3547–54. 17 indexed citations

Ritke, M K, et al.. (1989). Molecular analysis of chromosome 1 abnormalities in neuroblastoma. Cytogenetic and Genome Research. 50(2-3). 84–90. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact